July 17, 2023
Author(s)
Samuel Oberdick, Kalina Jordanova, John Lundstrom, Giacomo Parigi, Megan Poorman, Gary Zabow, Katy Keenan
We have investigated the efficacy of superparamagnetic iron oxide nanoparticles (SPIONs) as positive T1 contrast agents for low-field magnetic resonance imaging (MRI) at 64 millitesla (mT). Iron-oxide based agents, such as the FDA-approved ferumoxytol